JCI-accredited · 45+ hospitals & clinics · 90+ countries served · 24/7 multilingual support
Prof. Dr. Hüseyin Engin Medical Oncology

Prof. Dr. Hüseyin Engin

✓ Medically verified profile
Medical Oncology

Prof. Dr. Hüseyin Engin

✓ Medically verified profile
32+ years experienceLanguages: Turkish, EnglishOnline consultationAcibadem Atasehir Hospital · İstanbul
★★★★★ From 2,400+ verified Acibadem patient reviews
Prof. Dr. Hüseyin Engin
Profile

About Prof. Dr. Hüseyin Engin

Quick answer

Prof. Dr. Hüseyin Engin is a Medical Oncology specialist at Acibadem Atasehir Hospital in İstanbul with more than 32 years of experience.

He treats breast cancer, non-metastatic triple-negative breast cancer, metastatic pancreatic cancer, stage IIIB/IV non-small cell lung cancer, colorectal cancer, metastatic renal cell carcinoma, and bone metastases, and provides neoadjuvant chemotherapy, gemcitabine and gemcitabine-cisplatin chemotherapy, metronomic vinorelbine, zoledronic acid, interferon alpha, and tyrosine kinase inhibitor therapy. He consults in Turkish and…

Prof. Hüseyin Engin is a medical oncologist with a strong clinical and professional background. He earned his medical oncology training at Hacettepe University Faculty of Medicine in 2003. He is currently affiliated with Acıbadem Health Group (2025). He is an active member of several professional organizations, including the Turkish Oncology Group Films Alumni Club (FAC), the European Society for Medical Oncology (ESMO), the Turkish Internal Medicine Specialty Society, and the Medical Oncology Society. His memberships reflect a commitment to ongoing collaboration, education, and excellence in cancer care.

Meet the Doctor

Meet Prof. Dr. Hüseyin Engin

Hüseyin Engin, Professor of Medical OncologyHüseyin Engin, Professor of Medical Oncology
Clinical Focus

Areas of Expertise

Conditions treated and procedures performed by this specialist.

Breast cancerNon-metastatic triple-negative breast cancerMetastatic pancreatic cancerStage IIIB/IV non-small cell lung cancerColorectal cancerMetastatic renal cell carcinomaBone metastasesNeoadjuvant chemotherapyGemcitabine chemotherapyGemcitabine-cisplatin chemotherapyMetronomic vinorelbine therapyZoledronic acid therapyInterferon alpha therapyTyrosine kinase inhibitor therapy
Background

Education

  • 2003Hacettepe University Faculty of Medicine Medical Oncology
  • 1999Hacettepe University Faculty of Medicine Internal Medicine
  • 1994Hacettepe University Faculty of Medicine
Career

Professional Experience

  • 2025Acibadem Health Group
  • 2021Şişli Hamidiye Etfal Training and Research Hospital / Prof. Dr.
  • 2012–2021Zonguldak Bülent Ecevit University Faculty of Medicine, Department of Internal Medicine, Division of Medical Oncology / Prof. Dr.
  • 2006–2012Zonguldak Bülent Ecevit University Faculty of Medicine, Department of Internal Medicine, Division of Medical Oncology / Assoc. Dr.
  • 2004–2006Zonguldak Bülent Ecevit University Faculty of Medicine, Department of Internal Medicine, Division of Medical Oncology / Asst. Assoc. Dr.
  • 2004Private Zonguldak A Medical Center, Zonguldak / Specialist Doctor
  • 2003Burhan Nalbantoğlu State Hospital, Nicosia, TRNC / Specialist Doctor
  • 1999–2003Hacettepe University Faculty of Medicine / Department of Internal Medicine / Division of Medical Oncology / Assistant
  • 1999–2003Tumor Biology and Immunology MSc Degree Program, Hacettepe University Oncology Institute, Division of Basic Oncology / Special Student
  • 1994–1999Hacettepe University Faculty of Medicine, Department of Internal Medicine / Assoc. Assist. Dr.
Affiliations

Professional Memberships

  • Turkish Oncology Group Flims Alumni Club (FAC)
  • ESMO (European Society for Medical Oncology)
  • Turkish Internal Medicine Specialty Society
  • Medical Oncology Society
Research

Selected Publications

  • Intraoperative Ultrasonography-Guided Surgery; An effective modality for breast conservation after neo-adjuvant ehemotherapy Breast Journal. 2020;26:1680-1687 Taşdöven İ, Çakmak GK, Emre AU, Engin H. Bahadır B, Bakkal BH, Güllüoğlu MB.
  • Serum Sulphate Levels in Hemodialysis Patients Int J Nephrol. 2019 Dec 1;2019:1063514. doi: 10.1155/2019/1063514. eCollection 2019 Yildirim I, Hur E, Magden K, İlikhan S, Engin H, Can M, Yıldız G, Özer İ.
  • Comparison of Gemcitabine monotherapy with Gemcitabine and Cisplatin combination in metastatic pancreatic cancer: a retrospeetive analysis Urun Y. J BUON. 2018 Dec;23(7): 116-121. Ergun Y, Ozdemir NY, Guner EK, Esin E, Sendur MA, Koksoy EB, Demirci NS, Eren T, Dede I, Sezer A, Engin H, Oksuzoglu B, Yalcin B, Utkan G, Zengin N,
  • The effects of zoledronic acid on ECG: a prospeetive study on patients with bone metastatic cancer Clin Cases Miner Bone Metab. 2017 Jan-Apr; 14(1):35-39. doi: 10.11138/ccmbm/2017.14.1.035. Epub 2017 May 30. Demirtas D, Bilir C, Demirtas AO, Engin H.
  • Efficacv of metronomic vinorelbine in elderly patients with advanced non-small-cell lung cancer and poor performance status Curr Oncol. 2017 Jun;24(3):el99-e204. doi: 10.3747/co.24.3486. Epub 2017 Jun 27. Bilir C, Durak S, Kızılkaya B, Hacıbekiroglu I, Nayır E, Engin H.
  • Prognostic value of total lesion glycolysis in stage IIIB/IV nonesmall cell lung cancer. Journal of Oncological Sciences 3 (2017) 107-11 Yusufoglu B, Bilir C, Engin H.
  • A Study on the Relationship Between Leptin and Leptin Receptor Gene Variants and Colorectal Cancer. Muğla Sıtkı Koçman University Medical Journal. 2017;4(1): 10-14. Korkmaz N, Kimyon AS, Ermiş E, Edgünlü T, Arpacı E, Engin H. Karakaş Çelik S.
  • Using Interferon Alpha Before Tyrosine Kinase Inhibitors May Increase Survival in Patients With Metastatic Renal Celi Carcinoma: A Turkish Oncology Group (TOG) Study Clin Genitourin Cancer. 2016 Aug; 14(4):e347-53. Artaç M, Çoşkun HŞ, Korkmaz L, Koçer M, Turhal IMS, Engin H. Dede İ, Paydaş S, Öksüzoğlu B, Bozcuk H, Demirkazık A.
  • 10. Red Celi Distribution Width Has a Predictable Value for Differentiation of Provoked and Unprovoked Venous Thromboembolism Indian J Hematol Blood Transfus. 2016 Dec;32(4):481-487. Ertop S, Bilici M, Engin H, Buyukuysal C, Arslaner M, Toka B, Tekin
  • Increased serum tumor necrosis factor receptor-associated factor-6 expression in patients with non-metastatic triple-negative breast cancer Oncol Lett. 2015 Jun;9(6):2819-2824. Bilir C, Engin H, Can M, Likhan S, Demirtas D, Kuzu F, Bayraktaroglu T.
Good to Know

Frequently Asked Questions

What is Dr. Hüseyin Engin's specialty?
Dr. Hüseyin Engin is a specialist in Medical Oncology at Acibadem. For a personalised assessment, the Acibadem international patient team can review your medical history and reports and explain the suitable next steps.
Which hospital does Dr. Hüseyin Engin practise at?
Dr. Hüseyin Engin sees patients at Acibadem Atasehir Hospital in İstanbul. The international patient team can confirm current availability and help you plan a consultation or visit.
What languages can I use when consulting Dr. Hüseyin Engin?
Consultations with Dr. Hüseyin Engin are supported in Turkish and English. In addition, Acibadem provides multilingual coordination and interpreter support so international patients can communicate clearly throughout their care.
How can I book an appointment with Dr. Hüseyin Engin?
You can request an appointment with Dr. Hüseyin Engin using the appointment form on this page, or by contacting the Acibadem international patient team by phone or WhatsApp. After you share your details, the team checks availability and confirms your appointment, usually within 24 hours.
Is an online video consultation available with Dr. Hüseyin Engin?
Yes. Dr. Hüseyin Engin offers online video consultations, so you can discuss your condition and reports with the specialist before making any travel arrangements. The international patient team can help you schedule a secure video visit.
How many years of experience does Dr. Hüseyin Engin have?
Dr. Hüseyin Engin has around 32 years of professional experience in Medical Oncology. A summary of education, experience and professional memberships is available on this page.
Can international patients arrange treatment with Dr. Hüseyin Engin?
Yes. Acibadem supports international patients end to end — from the first consultation and treatment planning through appointment scheduling, interpretation during the stay and follow-up after returning home. Sharing your case for an initial assessment is free of charge.
How do I get a second opinion involving Dr. Hüseyin Engin?
You can request an independent review of your diagnosis and proposed treatment. Share your medical reports through the consultation or "Ask a Doctor" form on this site, and the team will arrange a specialist review and explain the available options.
Care without borders

A dedicated team, from first message to follow-up

Our international patient office coordinates your appointment, travel and treatment at JCI-accredited Acıbadem hospitals — and stays with you in your own language, every step of the way.

Book an Appointment

Schedule your appointment with Prof. Dr. Hüseyin Engin

Choose a date and time that suits you. Our international patient team will check availability and confirm your appointment — usually within 24 hours.

  1. 1
    Choose your date & timePick a preferred day and time slot for your visit.
  2. 2
    Share your detailsTell us how to reach you and anything we should know.
  3. 3
    We confirm with youOur team confirms the appointment by phone or email.
Why patients choose Acıbadem
35+Years of expertise
90+Countries served
20+Languages spoken
24/7Patient support
Prefer to talk now?
Appointment Request

Request your appointment

This request goes directly to this doctor’s schedule.

Prof. Dr. Hüseyin Engin Appointment with Hüseyin Engin Medical Oncology

Your information stays strictly confidential and is used only to arrange your care.

Where

Hospitals

Departments

Medical Units

Treatments

Treatments Performed

Patient Voices

What patients say about Prof. Dr. Hüseyin Engin

★★★★★From 2,400+ verified patient reviews
★★★★★ Verified Patient

“Choosing Acibadem for my infectious disease consultation was the best decision I made. Dr. Zengin explained every step clearly and never rushed me.”

Aisha N. · Bahrain February 2026
★★★★★ Verified Patient

“Years of worry ended once I came here for my lymphedema treatment. Dr. Zengin was honest about my options instead of pushing treatment.”

Ahmed P. · Kuwait April 2025
★★★★★ Verified Patient

“My cancer treatment was handled with real skill and genuine care. Prof. Dr. Engin explained every step clearly and never rushed me. The facilities were spotless and modern.”

Stefan J. · Bosnia and Herzegovina December 2025
We’re With You at Every Step

How can we help you today?

We value your privacy We use essential cookies to run this site and, with your consent, analytics cookies to understand how it is used and improve it. You can accept, reject, or choose what to allow. See our Cookie Policy.